An assay measuring soluble cytokeratin 19 fragments in the circulation, CYFRA 21-1, is a particularly useful tool in lung cancer [5], [6] and is mainly used in monitoring treatment and evaluating response to therapy in lung cancer. Here, KRT19 is linked to lung cancer.